1. Home
  2. ICG vs EQ Comparison

ICG vs EQ Comparison

Compare ICG & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

SELL

Current Price

$1.43

Market Cap

81.4M

Sector

Technology

ML Signal

SELL

Logo Equillium Inc.

EQ

Equillium Inc.

SELL

Current Price

$1.15

Market Cap

89.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ICG
EQ
Founded
2017
2017
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
89.4M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
ICG
EQ
Price
$1.43
$1.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$2.00
★ $8.56
AVG Volume (30 Days)
282.3K
★ 296.0K
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$109.44
N/A
P/E Ratio
$6.80
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$1.16
52 Week High
$2.28
$6.20

Technical Indicators

Market Signals
Indicator
ICG
EQ
Relative Strength Index (RSI) 59.34 34.91
Support Level $1.41 N/A
Resistance Level $1.52 $1.54
Average True Range (ATR) 0.08 0.12
MACD -0.01 0.00
Stochastic Oscillator 75.00 1.11

Price Performance

Historical Comparison
ICG
EQ

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: